Close Menu

EHR/EMR

Investigators intend to genotype the biorepository using Illumina arrays with the aim of identifying markers that can be used to inform treatment and prevention efforts.

The system allows oncologists to pick treatment regimens using NantHealth's decision support tool, and order them directly through Allscript's EHR system.

The service will be incorporated into the Washington-based healthcare system's EHR system in order to advance its precision medicine efforts.

Healthcare providers who use CGM EHR solutions can receive ActX real-time drug dosing, adverse reaction alerts, and patient genomic profiles.

The center, which is seen as a bellwether for integrating genomic information with EMRs, will use the data to inform efforts to prevent chronic, common diseases.

2bPrecise is developing the needed ontology for its platform to enable clinicians to combine genomic and clinical data in their interactions with pediatric patients.

The company plans to use Thermo Fisher Scientific's newly launched PharmacoScan array-based platform for its testing.

The researchers said that the goal was to design a model that other health care institutions could integrate in order to standardize PGx testing. 

Researchers were able to predict the expression of certain genes in 44 different tissues to predict other conditions that might later arise in patients as well as identify potential therapeutic approaches. 

Two research teams found potentially useful PGx variants in more than 1,000 participants in the NIH Undiagnosed Diseases Program, as well as in a handful of ClinSeq participants.

Pages

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.